| Name | Title | Contact Details |
|---|
Ram Medical Inc is a Wayne, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
EHE is America`s leading prevention company. We work with major clients from diverse fields to help their employees reach optimal health through comprehensive exams and year-round mentoring and resources. Our holistic, personalized approach improves longevity, productivity, and performance. For more than 100 years, EHE has led the way in preventive health care. We continue to grow and innovate, providing individuals with what they need to feel their best every day.
The only independent, free standing, non-profit home health care and hospice agency serving the South Shore, NVNA and Hospice provides care to over 27 communities from Milton to Plymouth. Ten-time winner of the national HomeCare Elite Top Agency award, Top 100 the last two years, NVNA and Hospice offers the full continuum of care from certified and private pay home care, to palliative and hospice care. Non-profit hospice residence, the Pat Roche Hospice Home, offers residential hospice care. Specialty services in Alzheimer`s, Diabetes, CHF, Chronic Disease Self Management, Wound Care, and Falls Prevention. Educational programs, free health screenings, and caregiver support groups also offered.
Roger Green and Associates is a New Hope, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III